Remove Acquisition Remove Arcturus Remove Develop Remove San Diego
article thumbnail

Xconomy Q&A: An Update with Arcturus Therapeutics CEO Joseph Payne

Xconomy

Things have been moving quickly in recent weeks for the San Diego RNA drug developer Arcturus Therapeutics. In a statement last week, Arcturus said it would work with Janssen to develop and commercialize its proprietary technologies for developing nucleic acid-based drug products for the treatment of hepatitis B.